Weight loss results vary by drug, with Rybelsus producing more modest losses (~6% in a year) and Foundayo and Wegovy producing results on par with injections (up to ~11%--14% in a year, respectively)
While significant weight loss becomes more apparent over time as the dosages are scaled up, it is not unusual for patients to notice subtle changes in their bodies during the first week
Nabeno M, Akahoshi F, Kishida H, Miyaguchi I, Tanaka Y, Ishii S, et al
These shortages have long since ended for semaglutide and tirzepatide, however, and both the FDA and Novo/Eli Lilly have sought to crack down on pharmacies widely making and selling these drugs
or a BMI of 27 or more if they have a weight-related complication
The home deliveries are enhancing patient convenience